arrow
E

Elisabetta Pupillo

istituto di ricerche farmacologiche mario negri irccs
H指数:32
被引数:3.3万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Air pollutants and amyotrophic lateral sclerosis in a population-based registry: investigating disease susceptibility, progression and survival

空气污染物与基于人群登记的肌萎缩侧索硬化症:探究疾病易感性、进展和生存情况

2026-05-280
PRE
Response to comments to “Prevalence and trajectories of post-COVID-19 neuromuscular conditions: A systematic-review and meta-analysis”

对“新冠后神经肌肉状况的患病率及轨迹:一项系统综述和荟萃分析”一文的评论回复

2026-02-260
PRE
Response to comments to “Prevalence and trajectories of post-COVID-19 neuromuscular conditions: A systematic-review and meta-analysis”

对“Post-COVID-19神经肌肉状况的患病率与轨迹:一项系统综述和荟萃分析”一文的评论回复

2026-02-110
PRE
Prevalence and trajectories of post-COVID-19 neuromuscular conditions: A systematic-review and meta-analysis

后COVID-19神经肌肉状况的患病率及演变轨迹:一项系统综述和荟萃分析

2025-12-250
PRE
Understanding Long-Term Survival in ALS: A Cohort Study on Subject Characteristics and Prognostic Factors

理解ALS的长期生存:一项关于受试者特征和预后因素的研究队列

2025-10-170
OAAI
Voluptuary Habits and Risk of Frontotemporal Dementia: A Case Control Retrospective Study

额颞痴呆的患病习惯和风险: 一项病例对照回顾性研究

2025-02-067
PREAI
Multicentre case-control study on the association between COVID-19 vaccines and neurological disorders (COVIVAX)

新型冠状病毒肺炎疫苗与神经系统疾病 (COVIVAX) 相关性的多中心病例对照研究

2025-02-040
OAAI
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology (vol 53, pg 1636, 2021)

肌萎缩性侧索硬化症的常见和罕见变异关联分析确定了15个具有不同遗传结构和神经元特异性生物学的风险位点 (第53卷,1636页,2021)

2022-01-311
OAAI
Common and rare variant association analyses in amyotrophic lateral sclerosis identify 15 risk loci with distinct genetic architectures and neuron-specific biology

肌萎缩性侧索硬化症的常见和罕见变异关联分析确定了15个具有不同遗传结构和神经元特异性生物学的风险位点

2021-12-06235
OAAI
Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: all-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019

全球、区域和国家在实现新生儿和儿童健康可持续发展目标3.2方面的进展: 全球疾病负担研究2019的全因和特定原因死亡率

LANCET
IF88.5
2021-09-01232
OAAI
Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019

基于1990至2019 204个国家和地区卫生服务有效覆盖指数衡量全民健康覆盖: 全球疾病负担研究2019的系统分析

LANCET
IF88.5
2020-10-01328
OAAI
Global burden of 87 risk factors in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019

1990至2019 204个国家和地区的87个风险因素的全球负担: 全球疾病负担研究2019的系统分析

LANCET
IF88.5
2020-10-017.7K
OAAI
Italy's health performance, 1990-2017: findings from the Global Burden of Disease Study 2017
2019-12-0159
OAAI
Effect modification of the association between total cigarette smoking and ALS risk by intensity, duration and time-since-quitting: Euro-MOTOR

通过戒烟的强度,持续时间和时间对总吸烟与ALS风险之间的关联进行效果修正: Euro-MOTOR

2019-08-2127
OAAI